Zepbound

The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

by

The blockbuster weight loss drug Wegovy has a new rival. Today, the US Food and Drug Administration approved a new drug for weight management called Zepbound, made by American pharmaceutical company Eli Lilly. The weekly injectable drug is meant for adults who are overweight or obese and have at least one weight-related condition, such as … Read more

FDA Approves Eli Lilly’s Zepbound, a Wegovy Competitor

by

There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly injectable drug will be sold under the brand name Zepbound. The New M3-Powered iMacs Are … Read more